牛牛AI助理已提取核心訊息
In8bio, Inc., a biotechnology company, has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company has proposed for the Registration Statement to become effective at 4:00 p.m. Eastern time on January 18, 2024. This request was made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended. In8bio's legal counsel, Cooley LLP, may reach out to the SEC staff to confirm the effective time or to request a different time if necessary. The company has designated Sarah Curry of Cooley LLP to be notified once the Registration Statement is declared effective by the SEC.
In8bio, Inc., a biotechnology company, has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company has proposed for the Registration Statement to become effective at 4:00 p.m. Eastern time on January 18, 2024. This request was made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended. In8bio's legal counsel, Cooley LLP, may reach out to the SEC staff to confirm the effective time or to request a different time if necessary. The company has designated Sarah Curry of Cooley LLP to be notified once the Registration Statement is declared effective by the SEC.
生物技術公司In8Bio, Inc. 已正式要求美國證券交易委員會（SEC）加快其S-3表格註冊聲明的生效日期。該公司已提議註冊聲明於美國東部時間2024年1月18日下午 4:00 生效。該請求是根據經修訂的1933年《證券法》下的《一般規則和條例》第461條提出的。In8bio的法律顧問Cooley LLP可能會聯繫美國證券交易委員會的工作人員以確認生效時間或在必要時要求不同的時間。該公司已指定在美國證券交易委員會宣佈註冊聲明生效後通知庫利律師事務所的莎拉·庫裏。
生物技術公司In8Bio, Inc. 已正式要求美國證券交易委員會（SEC）加快其S-3表格註冊聲明的生效日期。該公司已提議註冊聲明於美國東部時間2024年1月18日下午 4:00 生效。該請求是根據經修訂的1933年《證券法》下的《一般規則和條例》第461條提出的。In8bio的法律顧問Cooley LLP可能會聯繫美國證券交易委員會的工作人員以確認生效時間或在必要時要求不同的時間。該公司已指定在美國證券交易委員會宣佈註冊聲明生效後通知庫利律師事務所的莎拉·庫裏。
有用
沒用